Citation: Jg. Sarver et al., ETHOSUXIMIDE IS PRIMARILY METABOLIZED BY CYP3A WHEN INCUBATED WITH ISOLATED RAT-LIVER MICROSOMES, Drug metabolism and disposition, 26(1), 1998, pp. 78-82
Citation: Df. Liu et Ka. Bachmann, AN INVESTIGATION OF THE RELATIONSHIP BETWEEN ESTROGEN, ESTROGEN METABOLITES AND BLOOD CHOLESTEROL LEVELS IN OVARIECTOMIZED RATS, The Journal of pharmacology and experimental therapeutics, 286(1), 1998, pp. 561-568
Authors:
SLAMA JT
HANCOCK JL
RHO T
SAMBUCETTI L
BACHMANN KA
Citation: Jt. Slama et al., INFLUENCE OF SOME NOVEL N-SUBSTITUTED AZOLES AND PYRIDINES ON RAT HEPATIC CYP3A ACTIVITY, Biochemical pharmacology, 55(11), 1998, pp. 1881-1892
Authors:
SULLIVAN TJ
REESE JH
JAUREGUI L
MILLER K
LEVINE L
BACHMANN KA
Citation: Tj. Sullivan et al., A COMPARATIVE-STUDY OF THE INTERACTION BETWEEN ANTACID AND H-2-RECEPTOR ANTAGONISTS, Alimentary pharmacology & therapeutics, 8(1), 1994, pp. 123-126
Authors:
MICHAUD TJ
BACHMANN KA
ANDRES FF
FLYNN MG
SHERMAN GP
RODRIGUEZZAYAS J
Citation: Tj. Michaud et al., EXERCISE TRAINING DOES NOT ALTER CYTOCHROME-P-450 CONTENT AND MICROSOMAL METABOLISM, Medicine and science in sports and exercise, 26(8), 1994, pp. 978-982
Authors:
BACHMANN KA
SULLIVAN TJ
JAUREGUI L
REESE JH
MILLER K
LEVINE L
Citation: Ka. Bachmann et al., ABSENCE OF AN INHIBITORY EFFECT OF OMEPRAZOLE AND NIZATIDINE ON PHENYTOIN DISPOSITION, A MARKER OF CYP2C ACTIVITY, British journal of clinical pharmacology, 36(4), 1993, pp. 380-382
Citation: Ka. Bachmann et L. Jauregui, USE OF SINGLE SAMPLE CLEARANCE ESTIMATES OF CYTOCHROME-P450 SUBSTRATES TO CHARACTERIZE HUMAN HEPATIC CYP STATUS INVIVO, Xenobiotica, 23(3), 1993, pp. 307-315